Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Derm Allergy/Immunology

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study

Allergy | May 26, 2021 Derm Allergy/Immunology

Internet-delivered cognitive behavior therapy for atopic dermatitis: A randomized clinical trial

JAMA | May 24, 2021 Derm Allergy/Immunology

Improvement of clinical and immunological parameters after allergen-specific immunotherapy in atopic dermatitis

Journal of the European Academy of Dermatology and Venereology | May 22, 2021 Derm Allergy/Immunology

A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial

Dermatologic Therapy | May 20, 2021 Derm Allergy/Immunology

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

JAMA | May 17, 2021 Derm Allergy/Immunology

Pharmacokinetics of ruxolitinib in patients with atopic dermatitis treated with ruxolitinib cream: Data from phase II and III studies

American Journal of Clinical Dermatology | May 16, 2021 Derm Allergy/Immunology

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

JAMA Dermatology | May 15, 2021 Derm Allergy/Immunology

Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: A case series

JAMA Dermatology | May 15, 2021 Derm Allergy/Immunology

Association between metabolic syndrome and Behçet's disease: A nationwide population‐based study

The Journal of Dermatology | May 12, 2021 Derm Allergy/Immunology

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

British Journal of Dermatology | May 09, 2021 Derm Allergy/Immunology

« Prev 1 … 11 12 13 14 15 … 57 Next »

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study

Internet-delivered cognitive behavior therapy for atopic dermatitis: A randomized clinical trial

Improvement of clinical and immunological parameters after allergen-specific immunotherapy in atopic dermatitis

A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Pharmacokinetics of ruxolitinib in patients with atopic dermatitis treated with ruxolitinib cream: Data from phase II and III studies

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: A case series

Association between metabolic syndrome and Behçet's disease: A nationwide population‐based study

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study

Internet-delivered cognitive behavior therapy for atopic dermatitis: A randomized clinical trial

Improvement of clinical and immunological parameters after allergen-specific immunotherapy in atopic dermatitis

A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Pharmacokinetics of ruxolitinib in patients with atopic dermatitis treated with ruxolitinib cream: Data from phase II and III studies

Long-term efficacy of baricitinib in adults with moderate to severe atopic dermatitis who were treatment responders or partial responders: An extension study of 2 randomized clinical trials

Delayed localized hypersensitivity reactions to the Moderna COVID-19 vaccine: A case series

Association between metabolic syndrome and Behçet's disease: A nationwide population‐based study

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic